Prevalence and risk factors for multi-drug resistant bacterial infections in patients undergoing endoscopic retrograde cholangiopancreatography

Dig Liver Dis. 2023 Oct;55(10):1447-1449. doi: 10.1016/j.dld.2023.06.018. Epub 2023 Jul 3.

Endoscopic Infection Control Group:
Marco Rissone⁵, Anna Odone⁵, Catherine Klersy⁶, Annalisa De Silvestri⁶, Federico De Grazia⁷, Patrizia Cambieri⁸

¹ Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; Internal Medicine Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
² Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
³ Medical Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁴ Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; Internal Medicine Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: a.disabatino@smatteo.pv.it.
⁵ Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
⁶ Clinical Epidemiology and Biometry Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁷ Gastroenterology and Digestive Endoscopy Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁸ Microbiology and Virology Unit Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

No abstract available

Keywords: Antibiotics; Cholangitis; Endoscopy; Enterobacteriaceae; Nosocomial infection; Sepsis.

Publication types